Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Industry Research Methodology 11
1.2.2 Industry Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Industry Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Industry Overview and Dynamics 20
2.1 Industry Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Industry 24
2.2 Major Growth Drivers 26
2.3 Industry Restraints and Challenges 29
2.4 Emerging Opportunities and Industry Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of North America Industry by Formulation 40
3.1 Industry Overview by Formulation 40
3.2 Tablets 42
3.3 Capsules 43
3.4 Injectable 44
3.5 Sprays 45
3.6 Suspensions 46
3.7 Powders 47
3.8 Other Formulations 48
4 Segmentation of North America Industry by Route of Administration 49
4.1 Industry Overview by Route of Administration 49
4.2 Oral Medicine 51
4.3 Topical Medicine 52
4.4 Parenteral Medicine 53
4.5 Inhalations 54
4.6 Other Routes of Administration 55
5 Segmentation of North America Industry by Age Group 56
5.1 Industry Overview by Age Group 56
5.2 Children & Adolescents 58
5.3 Adults 59
5.4 Geriatric 60
6 Segmentation of North America Industry by Therapeutic Application 61
6.1 Industry Overview by Therapeutic Application 61
6.2 Cardiovascular Diseases 63
6.3 Pain 64
6.4 Diabetes 65
6.5 Cancer 66
6.6 Respiratory Diseases 67
6.7 Neurological Diseases 68
6.8 Orthopedics 69
6.9 Other Applications 70
7 Segmentation of North America Industry by Drug Type 71
7.1 Industry Overview by Drug Type 71
7.2 Branded Prescription Drugs 73
7.3 Generic Prescription Drugs 74
7.4 OTC Drugs 75
8 Segmentation of North America Industry by Distribution Channels 76
8.1 Industry Overview by Distribution Channels 76
8.2 Retail Channels 78
8.3 Non-retail Channels 79
9 Segmentation of North America Industry by Manufacturing Facility 80
9.1 Industry Overview by Manufacturing Facility 80
9.2 In-house Facility 82
9.3 Outsourced Facility 83
10 North America Industry 2020-2027 by Country 84
10.1 Overview of North America Industry 84
10.2 U.S. 87
10.3 Canada 91
10.4 Mexico 93
11 Competitive Landscape 95
11.1 Overview of Key Vendors 95
11.2 New Product Launch, Partnership, Investment, and M&A 98
11.3 Company Profiles 99
Abbott Laboratories 99
Aenova Group 101
Amgen 102
AstraZeneca 103
Catalent Inc. 104
Eli Lilly and Company 105
F. Hoffmann-La Roche Ltd. 106
Gilead Sciences 107
GlaxoSmithKline plc 108
Johnson & Johnson 109
Lonza Group 110
Lupin 111
Merck & Co., Inc. 112
Novartis AG 113
Novo Nordisk 114
Pfizer, Inc. 115
Roche 116
Sanofi SA 117
Takeda 118
12 Investing in North America Industry: Risk Assessment and Management 119
12.1 Risk Evaluation of North America Industry 119
12.2 Critical Success Factors (CSFs) 122
Related Reports and Products 125